Showing results (261-270 of 294) with videos related to
Sort By:
Pageof 30
Allergy|September 28, 2006
Tissue remodelling in upper airways: where is the link with lower airway remodelling?J-B Watelet, T Van Zele, M Gjomarkaj, et al.Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|July 27, 1999
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III studyP E Gallenga, L Lobefalo, L Colangelo, et al.Allergy|November 25, 2017
Perspectives in allergen immunotherapy: 2017 and beyondO Pfaar, S Bonini, V Cardona, et al.Allergy|August 12, 2008
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy)L B Schwartz, L Delgado, T Craig, et al.Allergy|September 2, 2005
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN networkL Heinzerling, A J Frew, C Bindslev-Jensen, et al.Allergy|February 28, 2007
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways documentN G Papadopoulos, P Xepapadaki, P Mallia, et al.Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.The European Respiratory Journal|June 27, 2008
The relation between paracetamol use and asthma: a GA2LEN European case-control studyS Shaheen, J Potts, L Gnatiuc, et al.Allergy|September 24, 2009
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in EuropeG J Burbach, L M Heinzerling, G Edenharter, et al.Pageof 30